Japan's Astellas Pharma Inc. appointed Kenji Yasukawa CEO and president, effective April 1.
Yasukawa is executive vice president of the pharmaceutical company. He will remain a representative director following the transition.
Further, Yoshihiko Hatanaka, Astellas' current CEO and president, will serve as chairman of the board starting April 1. He will also remain a representative director following the transition.
